9:32 PM · 19 November 2021

Workday stock falls despite upbeat quarterly earnings

Workday
Stocks
WDAY.US, Workday Inc - class A
-
-

Workday (WDAY.US) stock plunged more than 7% early in the session before erasing some losses in the afternoon despite better than expected quarterly results. Workday earned $1.10 per share, well above analysts’ estimates of 0.87 cents per share. Revenue climbed 20% to $1.33 billion beating Wall Street estimates of $1.31 billion amid faster growth in subscription revenue which increased 21% to $1.17 billion, edging by estimates of $1.16 billion. However, the company said the effects of the Covid-19 pandemic will weigh on growth in the coming year and the stock tumbled 7.3% in premarket trading. For the current quarter ending in January, the company expects subscription revenue of $1.217 billion at the midpoint of its guidance compared to market projections of $1.207 billion.

Workday (WDAY.US) stock launched today's session with a bearish price gap however sellers failed to break below the support at $277.60 which is marked with lower limit of the 1:1 structure and 38.2% Fibonacci retracement of the upward wave launched in mid-August. Later in the session buyers become more active and price rebounded. Currently stock is testing 50 SMA ( green line). If buyers manage to stay above it, the upward move may continue towards all-time high at $307.20. Source: xStation5

15 October 2025, 8:10 PM

TSMC Earnings Preview: Will the Key Semiconductor Supplier Surprise the Market?

15 October 2025, 6:05 PM

US Open: American Indices Rally on Anticipated End of Fed Balance Sheet Reduction

15 October 2025, 5:53 PM

Bank of America, Wells Fargo, and Morgan Stanley: Q3 2025 Earnings Overview

15 October 2025, 4:24 PM

Abbott reports no surprises in Q3, but tariff risks and lowered forecasts drag the share price down💡

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 1 700 000 investors from around the world